𝐆𝐥𝐨𝐛𝐚𝐥 𝐧𝐮𝐜𝐥𝐞𝐚𝐫 𝐢𝐦𝐚𝐠𝐢𝐧𝐠 𝐞𝐪𝐮𝐢𝐩𝐦𝐞𝐧𝐭 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐚𝐭 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟔.𝟓𝟏% 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃𝟓𝟖𝟕𝟑.𝟑𝟗 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟔. During pandemic, inpatient and outpatient services were affected, therefore, diagnostic and therapeutic nuclear medicine procedured dropped. However, growing geriatic population as well as increasing chronic illness such as cancer, cardiovascular diseases, neurological disorders, among others are driving the growth of the market throgh 2026.
In terms of product type, global nuclear imaging equipment market is segregated into PET Imaging Systems and Gamma Camera Imaging Systems. The PET imaging system is expected to dominate the market and witness a higher growth as compared to Gamma Camera Imaging on account of the ability of the PET imaging system to provide high-resolution images.
Furthermore, PET imaging systems provide higher diagnostic accuracy and lower patient exposure to radioactive particles. Additionally, PET imaging systems have the capability of generating images of the chemical alterations happening within the tissues, such as sugar metabolism. PET can also provide quantitative estimates of blood flow. Global nuclear imaging equipment market is fragmented with companies such as Siemens Healthineers AG, GE Healthcare, Koninklijke Philips NV and Canon Medical Systems Corporation occupying 47% of the market share in 2021.